Autologous Stem Cell Transplant for Autoimmune Diseases
Phase 2
20
about 5.2 years
8–25
1 site in PA
What this study is about
This trial is testing a treatment called autologous stem cell transplant (ASCT) in children and young adults with autoimmune diseases like systemic lupus erythematosus (SLE) or systemic sclerosis (SSc). The goal is to see if ASCT can help remove the harmful, self-attacking immune system in these patients.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Depletion of CD3/CD19 in an autologous stem cell transplant
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Two-year progression free survival
Secondary: Change in quality of life, Event free survival (EFS), Overall survival (OS)
Immune